BILASIGN Tablet by Dr Precision is a non-sedating, long-acting antihistamine formulation containing 20 mg Bilastine per tablet, specifically designed for the effective management of allergic rhinitis (seasonal and perennial) and chronic idiopathic urticaria. Bilastine, the active pharmaceutical ingredient, selectively antagonizes peripheral H1 histamine receptors without crossing the blood-brain barrier, ensuring potent symptom relief without sedation or cognitive impairment. This rapid-acting antihistamine delivers noticeable symptom improvement within one hour of oral administration, providing 24-hour sustained relief that supports once-daily dosing for enhanced patient compliance and convenience. Manufactured under stringent WHO-GMP and international regulatory standards by Dr Precision, BILASIGN Tablet guarantees high-quality and precision formulation. It effectively alleviates symptoms such as nasal congestion, sneezing, rhinorrhea, itchy eyes, and urticaria-induced hives, facilitating improved daily function and quality of life for patients struggling with chronic or seasonal allergic conditions. Ideal for clinical use in allergy management, BILASIGN Tablet stands out for its efficacy, safety profile, and non-sedative properties.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | 20 mg Bilastine per tablet |
| Action | Selective peripheral H1 histamine receptor antagonist |
| Sedation | Non-sedating, does not impair cognitive function |
| Onset of Action | Symptom relief within 1 hour |
| Duration of Action | 24 hours, suitable for once-daily dosing |
| Indications | Symptomatic treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria |
| Manufacturing Standards | WHO-GMP and international regulatory compliant |
| Brand | Dr Precision |
| Formulation | Long-acting oral tablet |
| CNS Penetration | Minimal to none, ensuring lack of drowsiness |
| Attributes | Description |
|---|---|
| Dosage Form | Oral tablet |
| Dosage Strength | 20 mg per tablet |
| Pharmacological Class | Second-generation antihistamine |
| Receptor Target | H1 histamine receptor antagonist |
| Pharmacokinetics | Rapid onset (within 1 hour), 24-hour duration |
| Therapeutic Use | Allergic rhinitis (seasonal and perennial), chronic idiopathic urticaria |
| Packaging | Blister pack (pack size varies by supplier) |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Shelf Life | As per manufacturing batch standards (typically 2 years) |
| Manufacturer | Dr Precision |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
BILASIGN Tablet contains Bilastine, a selective peripheral H1 receptor antagonist with minimal penetration into the central nervous system, which prevents drowsiness or cognitive impairment commonly associated with first-generation antihistamines.
Yes, BILASIGN provides a 24-hour duration of action allowing for convenient once-daily dosing, enhancing compliance in the management of long-term allergic rhinitis and chronic idiopathic urticaria.
BILASIGN Tablet effectively relieves nasal congestion, sneezing, runny nose, itchy nose, and ocular symptoms such as itchy, red eyes, providing comprehensive symptomatic control.
Yes, it is indicated for chronic spontaneous (idiopathic) urticaria, helping to reduce hives, itching, and swelling associated with the condition through histamine receptor blockade.
BILASIGN Tablet is manufactured under strict WHO-GMP and international regulatory standards ensuring high-quality, safety, and efficacy in allergy management.
Brand: bilasign
Country Of Origin: India
BILASIGN Tablet is a non-sedating, long-acting antihistamine formulation containing Bilastine, a selective H1 receptor antagonist. It is indicated for the symptomatic treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria. With its high selectivity for peripheral H1 receptors and lack of penetration into the central nervous system, BILASIGN offers effective symptom control without causing drowsiness or impairing cognitive function. Manufactured under WHO-GMP and international regulatory standards, BILASIGN Tablet provides safe and sustained allergy relief suitable for daily use.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
BILASIGN Tablet is an advanced, second-generation antihistamine designed to manage a range of allergic conditions with minimal central nervous system side effects. The active pharmaceutical ingredient in BILASIGN is Bilastine, a highly selective H1 histamine receptor antagonist that provides potent peripheral antihistaminic effects without crossing the blood-brain barrier. This selective action ensures effective relief from allergy symptoms such as sneezing, nasal congestion, rhinorrhea, itchy eyes, and urticaria, while maintaining patient alertness and performance throughout the day.
Bilastine is known for its rapid onset of action, with noticeable symptom improvement within one hour of oral administration. Its effects last for 24 hours, making it suitable for once-daily dosing, which enhances compliance and convenience for patients. This is especially valuable for individuals suffering from chronic or seasonal allergic conditions, where consistent and long-term symptom control is essential for quality of life and daily productivity.
BILASIGN Tablet is primarily indicated for the treatment of allergic rhinitis, both seasonal and perennial, and chronic spontaneous urticaria. Allergic rhinitis is a widespread condition caused by hypersensitivity to environmental allergens such as pollen, dust mites, pet dander, and mold spores. It is characterized by symptoms like nasal congestion, runny nose, itchy nose, and sneezing, often accompanied by ocular symptoms like redness and tearing. Chronic urticaria, on the other hand, is marked by the spontaneous appearance of hives, itching, and swelling that persists for weeks or months without an identifiable trigger. In both conditions, the release of histamine from mast cells plays a key role, and blocking this histamine action at the receptor site is central to effective management.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
